cancer testing
-
StageZero on revenues being generated via testing operations, partners and a status report on the Aristotle test
In a recent InvestorIntel interview, Tracy Weslosky speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
StageZero Life Sciences’ Aristotle 10 in 1 cancer screening test looks set to launch in Q1 2021
StageZero Life Sciences Ltd. (TSX: SZLS) (‘StageZero’) has been developing their Aristotle 10 in 1 cancer screening test…
